questionText: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of introducing regular reporting to Parliament on (a) the progress and (b) the impact on private sector research and development of the Vol
answerText: The Department has no plans to re-instate the reports to Parliament on the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), which were a requirement under the 2014 The Pharmaceutical Price Regulation Scheme (PPRS). This requirement w...
heading: Voluntary Scheme for Branded Medicines Pricing and Access